Because the current histopathologic criteria for glioma diagnosis cannot accurately assess patient prognosis,8, 9, 10 we performed a prognosis‐based comprehensive analysis of HMGA2 in gliomas of grades to assess the diagnostic potential of HMGA2. The gene discussed is HMGA2; the disease is central nervous system cancer.